79528-51-1Relevant articles and documents
BIFUNCTIONAL COMPOUND AND ITS USE IN IMMUNOTHERAPY
-
Page/Page column 18-19, (2021/02/12)
The invention relates to a bifunctional compound that is, on one side, an agonist of the TLR4 and, on the other side, an important inhibitor of the PSMA. Said compound is useful in immunotherapy for the treatment and/or prevention of prostate cancer. Therefore, the invention also relates to the use of the compound and to the pharmaceutical composition comprising it.
Iodine-catalyzed one-pot acetalation-esterification reaction for the preparation of orthogonally protected glycosides
Jones, Rachel A.,Davidson, Robert,Tran, Anh Tuan,Smith, Nichola,Carmen Galan
experimental part, p. 1842 - 1845 (2010/10/18)
An iodine-catalyzed one-pot tandem acetalation-esterification reaction of thio- and O-glycosides has been developed providing a fast and mild route to orthogonally protected glycosides ready to be used as building blocks in glycosylation reactions.
Synthesis of phenyl 6-O-acyl-3-O-benzyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside
Ogawa, Tomoya,Nakabayashi, Satoru,Sasajima, Kikuo
, p. 308 - 312 (2007/10/02)
-